The gradual onset of effects, while sometimes frustrating, reflects the medication's design to minimize side effects while maximizing sustainable metabolic benefits over time
doi: 10.1111/dom.12808 67 WangC.LiC.PengH.YeZ.ZhangJ.LiuX.et al
In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
I wasnt open to looking into the actual science because of the fitspo harm it was causing
Medicare coverage is expected to begin through the GLP-1 Bridge program from July 1, 2026, at approximately $50 per month for eligible beneficiaries